AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AROA BIOSURGERY LTD

0.535

+0.0357.00%

Volume:259.55K

Turnover:137.86K

Market Cap:184.59M

PE:49.82

High:0.540

Open:0.515

Low:0.515

Close:0.500

52wk High:0.800

52wk Low:0.475

Shares:345.03M

Float Shares:258.64M

Volume Ratio:0.51

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.011

EPS(LYR):0.013

ROE:4.86%

ROA:3.09%

PB:2.31

PE(LYR):41.47

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Aroa Biosurgery Says Symphony DFU Trial Lifts 12-Week Complete Closure Rate to 55% vs 35% with Standard Care

Aroa Biosurgery Reports Low Infection Rates in 411-Patient Myriad Soft Tissue Reconstruction Study

Aroa Biosurgery Says Study Interim Results Show Low Infection Rates, No Adverse Events Related to Myriad Products

MT Newswires Live

ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/ARX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ARX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ARX.AU\",,,,,undefined,":{"symbol":"ARX.AU","market":"AU","secType":"STK","nameCN":"AROA BIOSURGERY LTD","latestPrice":0.535,"timestamp":1791349920000,"preClose":0.5,"halted":0,"volume":259547,"delay":0,"changeRate":0.07000000000000006,"nameEN":"AROA BIOSURGERY LTD","floatShares":258636705,"shares":345033235,"eps":0.010739,"marketStatus":"Not Yet Opened","change":0.035,"latestTime":"10-07 16:12:00 AEDT","open":0.515,"high":0.54,"low":0.515,"amount":137855,"amplitude":0.05,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.010739,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.5,"openAndCloseTimeList":[[1791327600000,1791349200000]],"volumeRatio":0.5086771067772666,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ARX.AU","preClose":0.5,"auctionPrice":0.535,"auctionVolume":247,"auction":3,"marketStatus":"盘后竞价","timestamp":1791349792277}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ARX.AU\",,,,,undefined,":{"symbol":"ARX.AU","floatShares":258636705,"roa":"3.09%","roe":"4.86%","lyrEps":0.0129,"volumeRatio":0.5086771067772666,"shares":345033235,"dividePrice":0,"high":0.54,"amplitude":0.05,"preClose":0.5,"low":0.515,"week52Low":0.475,"pbRate":"2.31","psRate":"2.21","week52High":0.8,"institutionHeld":0,"latestPrice":0.535,"eps":0.010739,"divideRate":0,"volume":259547,"delay":0,"ttmEps":0.010739,"open":0.515,"prevYearClose":0.74,"prevWeekClose":0.49,"prevMonthClose":0.525,"prevQuarterClose":0.525,"fiveDayClose":0.525,"twentyDayClose":0.545,"sixtyDayClose":0.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-05-26","symbol":"ARX.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1779753600000,"name":null,"time":"Pre-MKt","dateTimestamp":1779717600000,"actualEps":null},{"date":"2025-11-24","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763938800000,"name":null,"time":"","dateTimestamp":1763902800000,"actualEps":null},{"date":"2025-10-30","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761778800000,"name":null,"time":"","dateTimestamp":1761742800000,"actualEps":null},{"date":"2025-10-15","symbol":"ARX.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1760482800000,"name":null,"time":"Pre-MKt","dateTimestamp":1760446800000,"actualEps":null},{"date":"2025-07-28","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753660800000,"name":null,"time":"","dateTimestamp":1753624800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673177220","title":"Aroa Biosurgery Says Symphony DFU Trial Lifts 12-Week Complete Closure Rate to 55% vs 35% with Standard Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2673177220","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673177220?lang=en_us&edition=fundamental","pubTime":"2026-10-05 12:46","pubTimestamp":1791175575,"startTime":"0","endTime":"0","summary":"Aroa Biosurgery says Symphony DFU trial lifts 12-week complete closure rate to 55% vs 35% with standard careAroa Biosurgery reported results from a randomized trial of Symphony for diabetic foot ulcer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL9qkRp2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398527","title":"Aroa Biosurgery Reports Low Infection Rates in 411-Patient Myriad Soft Tissue Reconstruction Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398527","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398527?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:47","pubTimestamp":1788742049,"startTime":"0","endTime":"0","summary":"Aroa Biosurgery reports low infection rates in 411-patient Myriad soft tissue reconstruction studyAroa Biosurgery announced peer-reviewed interim results from its ongoing MASTRR Registry evaluating My","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL45rQDX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ARX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800754","title":"Aroa Biosurgery Says Study Interim Results Show Low Infection Rates, No Adverse Events Related to Myriad Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800754","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800754?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:57","pubTimestamp":1788483446,"startTime":"0","endTime":"0","summary":"Aroa Biosurgery  interim results from its study, which included 411 patients enrolled in the MASTRR Registry across 10 US centers and representing 474 soft tissue defects, reported low infection rates and no adverse events related to its Myriad products, according to a Friday Australian bourse filing.The ongoing prospective observational study is evaluating the real-world safety and performance of the Myriad Matrix and Myriad Morcells products across a range of complex soft tissue reconstruction procedures. The interim results were published in Advances in Therapy.Deep tissue infection occurred in only 0.7% of patients and superficial infection in 2.9%, according to the results. No infections were attributed to Myriad products, over a median follow-up period of 27 weeks. Across the 474 defects, the median number of Myriad product applications was one.Over 550 patients have been enrolled, and the registry is approved to enrol up to 800 patients across 15 sites in the US.Its shares rose ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","ARX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820966","title":"ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820966","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820966?lang=en_us&edition=fundamental","pubTime":"2026-08-25 03:04","pubTimestamp":1787598287,"startTime":"0","endTime":"0","summary":"As the Australian market looks to start the week on a positive note, buoyed by encouraging movements on Wall Street and a resilient commodities sector, investors are keenly observing opportunities for growth amidst fluctuating economic indicators like unemployment rates. In this environment, identifying stocks trading below their intrinsic value can offer potential advantages, as these investments may provide room for appreciation when market confidence is bolstered by favorable global and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/telecom/asx-slc/superloop-shares/news/asx-august-2026-stocks-estimated-to-be-trading-below-intrins","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/telecom/asx-slc/superloop-shares/news/asx-august-2026-stocks-estimated-to-be-trading-below-intrins","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELS.AU","BK4139","BK7055","CGS.AU","TLX","BK7505","BK7084","BK7501","ARX.AU","MSB.AU","BK7067","BK7094","BK7126","BK7508","SLC.AU","RDY.AU","BK4588","PNV.AU","ING.AU","BGL.AU","BK7016","SPHQ","BK7015","BK7141","TEA.AU","TLX.AU","BK4585","BK7104"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ARX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}